Covered recipient · General Payments record
ANJANA R CHHABRA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,956.79
- Reported across 114 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $287.57 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $157.05 | 10 |
| VIVUS LLC | $61.99 | 3 |
| Currax Pharmaceuticals LLC | $49.93 | 3 |
| Lilly USA, LLC | $18.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Currax Pharmaceuticals LLC | $14.59 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089509048 | CMS |
| Currax Pharmaceuticals LLC | $17.90 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089509050 | CMS |
| Currax Pharmaceuticals LLC | $17.44 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089509052 | CMS |
| Lilly USA, LLC | $18.60 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136040594 | CMS |
| Novo Nordisk Inc | $16.60 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097138185 | CMS |
| Novo Nordisk Inc | $14.13 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097486212 | CMS |
| Novo Nordisk Inc | $14.43 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097419129 | CMS |
| Novo Nordisk Inc | $15.84 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096621690 | CMS |
| Novo Nordisk Inc | $22.58 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097755818 | CMS |
| Novo Nordisk Inc | $13.61 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097265203 | CMS |
| Novo Nordisk Inc | $16.08 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096822455 | CMS |
| Novo Nordisk Inc | $14.93 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096667110 | CMS |
| Novo Nordisk Inc | $13.62 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097409017 | CMS |
| Novo Nordisk Inc | $15.23 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096572246 | CMS |
| VIVUS LLC | $22.36 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415082 | CMS |
| VIVUS LLC | $20.58 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415084 | CMS |
| VIVUS LLC | $19.05 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415086 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.